2027 Co-op Genome Engineering & Transgenic Model Development
Regeneron Pharmaceuticals
Summary
Regeneron is currently seeking a 2027 Co-op in Genome Engineering & Transgenic Model Development to join our VelociGene team, which develops next-generation gene-editing tools to improve the precision and safety of genome engineering for cell lines, mouse models, and future therapeutics.
Job description
When & where
Location: Tarrytown, NY. Our Co-op positions are full-time and onsite from January-August (Spring-Summer), May/June-December (Summer-Fall), and August-December (Fall).
What you'll do
- Contribute to the development of a proprietary gene-editing enhancement platform designed for both in vitro and in vivo use
- Screen engineered protein variants using a fluorescence-based reporter assay to identify compact, enhanced versions that retain function
- Apply computational structure-prediction tools to help design engineered protein variants
- Evaluate a modified, DNA-nicking version of Cas9 to assess whether it reduces unwanted genomic effects while preserving editing efficiency
- Perform basic molecular biology techniques such as polymerase chain reaction (PCR), cloning and subcloning, and western blotting
- Perform mammalian cell culture techniques, including sterile technique, passaging, and transfection or electroporation
- Work with viral vectors and flow cytometry methods
- Document experimental procedures and results using tools such as Excel and Prism, and collaborate with scientists across the VelociGene team
Relevant majors
Biology, Biomedical Engineering, Molecular Biology, Genetics, Chemistry
Let's find out if we're a fit
- Must be enrolled in, or accepted to, an academic program pursuing an Undergraduate or Graduate degree (and be returning to school the semester following the position or graduating after the position)
- Must be able to commit to 40 hours per week from January-August, May/June-December, or August-December
- Demonstrated leadership in areas such as campus activities, clubs, sports, current or previous work, or within the community preferred
- Cumulative GPA of 3.0 or higher preferred
Requirements
- Must be enrolled in, or accepted to, an academic program pursuing an Undergraduate or Graduate degree (and be returning to school the semester following the position or graduating after the position)
- Must be able to commit to 40 hours per week from January-August, May/June-December, or August-December
- Demonstrated leadership in areas such as campus activities, clubs, sports, current or previous work, or within the community preferred
- Cumulative GPA of 3.0 or higher preferred
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Insurance benefits
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.